Researchers isolated human platelet proteins with glutamate-binding activity, finding similarities to brain glutamate-binding proteins. This suggests potential roles for these platelet proteins in neurotransmission-related pathways.
Area of Science:
Biochemistry
Neuroscience
Molecular Biology
Context:
Platelets, traditionally known for hemostasis, are increasingly recognized for roles beyond blood clotting.
Glutamate is a major excitatory neurotransmitter in the central nervous system, with its receptors and binding proteins being crucial for synaptic function.
Understanding glutamate-binding proteins in non-neuronal cells like platelets can reveal novel physiological functions and potential therapeutic targets.
Purpose:
To isolate and characterize proteins from human platelets that exhibit glutamate-binding activity.
To compare the biochemical and immunochemical properties of these platelet proteins with known glutamate-binding proteins in the mammalian brain.
Summary:
Human platelet total membrane fraction was solubilized and subjected to affinity chromatography on glutamate agarose, yielding two fractions with glutamate-binding activity.
Radioligand binding assays revealed distinct binding site characteristics in the two fractions: Fraction 1 showed two types (Kd1 = 1 µM, Bmax1 = 100 pmol/mg; Kd2 = 9.3 µM, Bmax2 = 395 pmol/mg), while Fraction 2 exhibited one type (Kd = 1 µM, Bmax = 110 pmol/mg).
SDS-PAGE identified protein components in Fraction 1 (14, 24, 56, 155 kDa) and Fraction 2 (14, 46, 71, 155 kDa). Immunoenzymatic analysis confirmed significant immunochemical similarity between these platelet proteins and human brain synaptic membrane glutamate-binding proteins.
Impact:
This study identifies novel glutamate-binding proteins in human platelets, suggesting a potential role for platelets in modulating glutamatergic signaling.
The findings open avenues for investigating platelet function in neurological conditions where glutamate signaling is dysregulated.
The identified platelet glutamate-binding proteins could serve as potential biomarkers or therapeutic targets for diseases involving glutamate pathways.